SANTA CLARA, Calif.--(BUSINESS WIRE)--Nov. 6, 2008--XenoPort, Inc. (Nasdaq:XNPT) announced today that it will provide access via the World Wide Web to its presentations at the following upcoming conferences:

• Rodman & Renshaw 10th Annual Healthcare Conference
  Tuesday, November 11 at 12:25 p.m. Eastern Time
• Credit Suisse 2008 Healthcare Conference
  Thursday, November 13 at 10:30 a.m. Eastern Time

To access the live presentations via the Web, please go to www.XenoPort.com. Please connect to the Web site at least 15 minutes prior to the live presentation to ensure adequate time for any software downloads that may be necessary to listen to the Webcast.

A replay of each Webcast can be accessed for a minimum of one week and will be available approximately 24 hours after the respective live presentation.

About XenoPort

XenoPort, Inc. is a biopharmaceutical company focused on developing a portfolio of internally discovered product candidates that utilize the body's natural nutrient transport mechanisms to improve the therapeutic benefits of existing drugs. XenoPort is developing its lead product candidate in partnership with Astellas Pharma Inc. and GlaxoSmithKline. GlaxoSmithKline has filed with the U.S. Food and Drug Administration a new drug application for this product candidate, known as Solzira(TM) in the U.S., for the treatment of restless legs syndrome. XenoPort's product candidates are also being studied for the potential treatment of gastroesophageal reflux disease, migraine headaches, neuropathic pain, spasticity related to spinal chord injury, acute back spasms and Parkinson's disease.

To learn more about XenoPort, please visit the Web site at www.XenoPort.com.

XenoPort is a registered trademark Solzira is a U.S. trademark of GSK. XNPT2G

CONTACT: XenoPort, Inc.
Jackie Cossmon, 408-616-7220
ir@XenoPort.com

SOURCE: XenoPort, Inc.